---
figid: PMC5050441__pr.115.010843f33
figtitle: Multitargeted modulation of estrogen carcinogenesis by botanicals
organisms:
- Glycine max
- Medicago sativa
- Zingiber officinale
- Linum usitatissimum
- Silybum marianum
- Angelica sinensis
- Trifolium pratense
- Trigonella foenum-graecum
- Rheum rhabarbarum
- Humulus lupulus
- Valeriana officinalis
- Vaccinium macrocarpon
- Vitex agnus-castus
- Rheum rhaponticum
- Viburnum opulus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC5050441
filename: pr.115.010843f33.jpg
figlink: /pmc/articles/PMC5050441/figure/F33/
number: F33
caption: 'Multitargeted modulation of estrogen carcinogenesis by botanicals. Estrogen
  carcinogenesis involves numerous pathways: (1) Hormonal (); estrogen binds to ERα,
  which activates EREs to increase proliferation. (2) Chemical (, ); the aryl hydrocarbon
  receptor (AhR) is activated by AhR agonists, which increases P450 1A1 (benign pathway)
  and P450 1B1 (genotoxic pathway). Additionally, Nrf2-secondMaf binding to the antioxidant
  response element (ARE) increases NQO1 and phase II enzymes that detoxify genotoxic
  estrogen o-quinones, which initiate genotoxicity through DNA adducts and ROS produced
  from redox cycling between the catechol and estrogen-o-quinones. (3) Inflammatory
  (); inflammatory biomarkers, such as cytokines, increase aromatase expression, thus,
  increasing estrogen and feeding both the chemical and hormonal pathway. Cytokines,
  derived from chronic inflammation, macrophages or adipocytes, reportedly suppress
  P450 1A1, yet increase P450 1B1, most likely through the inflammatory mediator NF-κB.
  Cytokines also increase expression of genes (i.e., NF-κB, iNOS, COX-2) in epithelial
  and malignant cells that are often overexpressed in breast cancer patients. (4)
  Epigenetic (); epigenetic events through ERα inhibit expression of P450 1A1 by encouraging
  hypermethylation of its promoter, whereas having no significant effect on P450 1B1
  expression. Green arrows represent potential positive effects of botanicals, whereas
  red arrows represent negative effects in each pathway.'
papertitle: Botanicals and Their Bioactive Phytochemicals for Women’s Health.
reftext: Birgit M. Dietz, et al. Pharmacol Rev. 2016 Oct;68(4):1026-1073.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9551325
figid_alias: PMC5050441__F33
figtype: Figure
redirect_from: /figures/PMC5050441__F33
ndex: 95b72597-deeb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5050441__pr.115.010843f33.html
  '@type': Dataset
  description: 'Multitargeted modulation of estrogen carcinogenesis by botanicals.
    Estrogen carcinogenesis involves numerous pathways: (1) Hormonal (); estrogen
    binds to ERα, which activates EREs to increase proliferation. (2) Chemical (,
    ); the aryl hydrocarbon receptor (AhR) is activated by AhR agonists, which increases
    P450 1A1 (benign pathway) and P450 1B1 (genotoxic pathway). Additionally, Nrf2-secondMaf
    binding to the antioxidant response element (ARE) increases NQO1 and phase II
    enzymes that detoxify genotoxic estrogen o-quinones, which initiate genotoxicity
    through DNA adducts and ROS produced from redox cycling between the catechol and
    estrogen-o-quinones. (3) Inflammatory (); inflammatory biomarkers, such as cytokines,
    increase aromatase expression, thus, increasing estrogen and feeding both the
    chemical and hormonal pathway. Cytokines, derived from chronic inflammation, macrophages
    or adipocytes, reportedly suppress P450 1A1, yet increase P450 1B1, most likely
    through the inflammatory mediator NF-κB. Cytokines also increase expression of
    genes (i.e., NF-κB, iNOS, COX-2) in epithelial and malignant cells that are often
    overexpressed in breast cancer patients. (4) Epigenetic (); epigenetic events
    through ERα inhibit expression of P450 1A1 by encouraging hypermethylation of
    its promoter, whereas having no significant effect on P450 1B1 expression. Green
    arrows represent potential positive effects of botanicals, whereas red arrows
    represent negative effects in each pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - NFKBIA
  - PTGS2
  - NOS2
  - ISYNA1
  - NFKB1
  - AHR
  - ESR1
  - ERAL1
  - KEAP1
  - ESR2
  - GABPA
  - NFE2L2
  - ARNT
  - MIA3
  - MAL
  - MRTFA
  - TIRAP
  - PNMA1
  - GSTZ1
  - CYP2B6
  - CYP1B1
  - SLC45A2
  - IKKepsilon
  - key
  - IKKbeta
  - COX2
  - Inos
  - Nos
  - Dif
  - dl
  - Rel
  - ss
  - era
  - Keap1
  - GluProRS
  - cnc
  - tgo
  - Me
  - mal
  - bs
  - Mrtf
  - Cyp4g1
  - Cyp4d1
  - Cyp4d2
  - Cyp4ae1
  - Cyp18a1
  - Cpr
  - Cyp4e3
  - Cyp6a2
  - Cyp9b1
  - Cyp9b2
  - Cyp4e2
  - Cyp6a9
  - Cyp6a20
  - Cyp6a21
  - Cyp6a8
  - Cyp9c1
  - Cyp4d8
  - Cyp12a4
  - Cyp4c3
  - Cyp4e1
  - Cyp4p1
  - Cyp6a22
  - hts
  - l(3)1A1
  - Estrogen
  - Quinone
---
